This Biotech Has a Pipeline That Could Redefine Its Entire Therapeutic Area [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
Challenging economic conditions have led investors to rotate their money out of somewhat speculative investments, and it also doesn't help that the biotech's only approved medicine has, so far, generated little revenue. However, there is one key reason the stock could still deliver outstanding returns over the long run: Its pipeline could help redefine an entire therapeutic area. Let's dig in. Image source: Getty Images. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Shooting for the stars CRISPR Therapeutics has a fair number of pipeline candidates for a biotech worth a bit under $5 billion. Using its gene-editing platform, the company is targeting various areas with high unmet needs. Some of its most promising products in development are aiming to address risk factors for cardiovascular disease. Consider,
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics AG (CRSP) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare ConferenceGlobeNewswire
- The cutting-edge treatment that could lower dangerously high cholesterol [MSNBC.com]MSNBC.com
- A one-time treatment tweaked their genes — and lowered their cholesterol [MSNBC.com]MSNBC.com
- Assessing CRISPR Therapeutics (CRSP) Valuation As Recent Returns Send Mixed Signals [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 4/2/26 - Form PRE
- 3/24/26 - Form 4
- 3/24/26 - Form 4
- CRSP's page on the SEC website